- Home
- GHRS vs CTS Comparison
GHRS vs CTS Comparison
Compare GHRS & CTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GHRS | CTS |
|---|---|---|
| Founded | 2018 | 1896 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Electrical Products |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.8B |
| IPO Year | 2021 | 1994 |
Fundamental Metrics
Financial Performance| Metric | GHRS | CTS |
|---|---|---|
| Price | $23.18 | $58.72 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $41.38 | N/A |
| AVG Volume (30 Days) | ★ 150.4K | 149.9K |
| Earning Date | 05-01-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 0.29% |
| EPS Growth | N/A | ★ 15.87 |
| EPS | N/A | ★ 0.59 |
| Revenue | N/A | ★ $541,318,000.00 |
| Revenue This Year | N/A | $5.55 |
| Revenue Next Year | N/A | $5.00 |
| P/E Ratio | ★ N/A | $101.03 |
| Revenue Growth | N/A | ★ 4.95 |
| 52 Week Low | $12.04 | $36.03 |
| 52 Week High | $31.44 | $69.55 |
Technical Indicators
Market Signals| Indicator | GHRS | CTS |
|---|---|---|
| Relative Strength Index (RSI) | 26.61 | 54.30 |
| Support Level | $19.75 | $58.56 |
| Resistance Level | $25.30 | $59.66 |
| Average True Range (ATR) | 1.29 | 1.41 |
| MACD | -0.50 | 0.47 |
| Stochastic Oscillator | 5.58 | 71.54 |
Price Performance
Historical ComparisonAbout GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
About CTS CTS Corporation
CTS Corp operates in the electronics industry. The company is a manufacturer of Sensors, Electronic components, and Actuators. It designs, manufactures, and sells a broad line of sensors, electronic components, and actuators mainly to original equipment manufacturers (OEMs) for the aerospace and defense, industrial, information technology, medical, telecommunications, and transportation markets. Geographically, it derives a majority of its revenue from the United States and also has a presence in China, Singapore, the Czech Republic, Taiwan, Denmark, and other countries.